|
1
|
Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
|
Hepatology
|
2011
|
1.87
|
|
2
|
Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection.
|
Liver Int
|
2007
|
1.80
|
|
3
|
Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
|
Liver Int
|
2012
|
1.79
|
|
4
|
Genome replication, virion secretion, and e antigen expression of naturally occurring hepatitis B virus core promoter mutants.
|
J Virol
|
2003
|
1.79
|
|
5
|
Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization.
|
Clin Cancer Res
|
2012
|
1.67
|
|
6
|
The accuracy of noninvasive methods in predicting the development of hepatocellular carcinoma and hepatic decompensation in patients with chronic hepatitis B.
|
J Clin Gastroenterol
|
2012
|
1.63
|
|
7
|
Clarification required for the definition of hepatitis B virus subgenotypes C1 and C2.
|
Intervirology
|
2009
|
1.60
|
|
8
|
Natural history of hepatitis B virus-related cirrhotic patients hospitalized to control ascites.
|
J Gastroenterol Hepatol
|
2008
|
1.55
|
|
9
|
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B.
|
Gut
|
2013
|
1.46
|
|
10
|
Prospective validation of P2/MS noninvasive index using complete blood counts for detecting oesophageal varices in B-viral cirrhosis.
|
Liver Int
|
2010
|
1.46
|
|
11
|
Variability in liver stiffness values from different intercostal spaces.
|
Liver Int
|
2009
|
1.45
|
|
12
|
Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean.
|
PLoS One
|
2012
|
1.44
|
|
13
|
Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis.
|
PLoS One
|
2012
|
1.43
|
|
14
|
Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
|
J Gastroenterol Hepatol
|
2004
|
1.39
|
|
15
|
Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.
|
Cancer
|
2008
|
1.36
|
|
16
|
Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.
|
Dig Dis Sci
|
2008
|
1.35
|
|
17
|
Hepatocellular carcinoma presenting with bone metastasis: clinical characteristics and prognostic factors.
|
J Cancer Res Clin Oncol
|
2008
|
1.34
|
|
18
|
Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.
|
Hepatology
|
2011
|
1.29
|
|
19
|
Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.
|
Liver Int
|
2013
|
1.27
|
|
20
|
HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B.
|
Antivir Ther
|
2011
|
1.26
|
|
21
|
Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
|
Liver Int
|
2010
|
1.25
|
|
22
|
MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
|
Carcinogenesis
|
2008
|
1.25
|
|
23
|
Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis.
|
PLoS One
|
2012
|
1.24
|
|
24
|
MRP2 haplotypes confer differential susceptibility to toxic liver injury.
|
Pharmacogenet Genomics
|
2007
|
1.23
|
|
25
|
Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
|
Liver Int
|
2007
|
1.21
|
|
26
|
Long-term adefovir dipivoxil monotherapy for up to 5 years in lamivudine-resistant chronic hepatitis B.
|
Antivir Ther
|
2010
|
1.18
|
|
27
|
Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B.
|
J Med Virol
|
2010
|
1.18
|
|
28
|
Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis.
|
J Clin Gastroenterol
|
2009
|
1.17
|
|
29
|
Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.
|
Yonsei Med J
|
2005
|
1.17
|
|
30
|
Normal controlled attenuation parameter values: a prospective study of healthy subjects undergoing health checkups and liver donors in Korea.
|
Dig Dis Sci
|
2014
|
1.16
|
|
31
|
A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis.
|
Am J Gastroenterol
|
2010
|
1.15
|
|
32
|
Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma.
|
Liver Int
|
2010
|
1.15
|
|
33
|
Long-term outcome of chronic hepatitis B based on histological grade and stage.
|
J Gastroenterol Hepatol
|
2007
|
1.15
|
|
34
|
Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation.
|
Dig Dis Sci
|
2012
|
1.14
|
|
35
|
Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model.
|
Am J Gastroenterol
|
2011
|
1.14
|
|
36
|
Modulation of hepatitis B virus secretion by naturally occurring mutations in the S gene.
|
J Virol
|
2004
|
1.13
|
|
37
|
Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.
|
PLoS One
|
2012
|
1.12
|
|
38
|
How can we enhance the performance of liver stiffness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B?
|
J Clin Gastroenterol
|
2010
|
1.12
|
|
39
|
Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B.
|
Hepatology
|
2010
|
1.11
|
|
40
|
Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.
|
Cancer
|
2007
|
1.11
|
|
41
|
Evaluation of methods for monitoring drug resistance in chronic hepatitis B patients during lamivudine therapy based on mass spectrometry and reverse hybridization.
|
Antivir Ther
|
2005
|
1.10
|
|
42
|
Comparison of multiplex restriction fragment mass polymorphism and sequencing analyses for detecting entecavir resistance in chronic hepatitis B.
|
Antivir Ther
|
2011
|
1.07
|
|
43
|
Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib.
|
Liver Int
|
2011
|
1.06
|
|
44
|
Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation.
|
Eur J Cancer
|
2012
|
1.06
|
|
45
|
High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms.
|
Adv Ther
|
2015
|
1.06
|
|
46
|
Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea.
|
Yonsei Med J
|
2011
|
1.05
|
|
47
|
PIVKA-II is a useful tumor marker for recurrent hepatocellular carcinoma after surgical resection.
|
Oncology
|
2007
|
1.04
|
|
48
|
Changes in serum and ascitic monocyte chemotactic protein-1 (MCP-1) and IL-10 levels in cirrhotic patients with spontaneous bacterial peritonitis.
|
J Interferon Cytokine Res
|
2007
|
1.03
|
|
49
|
Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma.
|
Eur J Cancer
|
2011
|
1.03
|
|
50
|
Prediction of microvascular invasion before curative resection of hepatocellular carcinoma.
|
J Surg Oncol
|
2008
|
1.02
|
|
51
|
Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B.
|
Antivir Ther
|
2011
|
1.02
|
|
52
|
Clinical characteristics and treatment outcomes of hepatocellular carcinoma with inferior vena cava/heart invasion.
|
Anticancer Res
|
2011
|
1.01
|
|
53
|
Prospective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.
|
PLoS One
|
2012
|
1.00
|
|
54
|
Prediction of postoperative hepatic insufficiency by liver stiffness measurement (FibroScan((R))) before curative resection of hepatocellular carcinoma: a pilot study.
|
Hepatol Int
|
2008
|
1.00
|
|
55
|
How many valid measurements are necessary to assess liver fibrosis using FibroScan® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements.
|
Yonsei Med J
|
2012
|
1.00
|
|
56
|
What are 'true normal' liver stiffness values using FibroScan?: a prospective study in healthy living liver and kidney donors in South Korea.
|
Liver Int
|
2009
|
0.99
|
|
57
|
Anti-hepatitis A virus seroprevalence among patients with chronic viral liver disease in Korea.
|
Eur J Gastroenterol Hepatol
|
2007
|
0.99
|
|
58
|
Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma.
|
Clin Cancer Res
|
2006
|
0.98
|
|
59
|
Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
|
Oncology
|
2007
|
0.98
|
|
60
|
Clinical outcome of renal transplantation in patients with positive pre-transplant hepatitis B surface antigen.
|
J Med Virol
|
2007
|
0.98
|
|
61
|
Ascites and spontaneous bacterial peritonitis: an Asian perspective.
|
J Gastroenterol Hepatol
|
2009
|
0.98
|
|
62
|
Evolution of hepatitis B virus sequence from a liver transplant recipient with rapid breakthrough despite hepatitis B immune globulin prophylaxis and lamivudine therapy.
|
J Med Virol
|
2003
|
0.98
|
|
63
|
Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
|
J Med Virol
|
2009
|
0.98
|
|
64
|
Clinical features and prognosis of spontaneous bacterial peritonitis in korean patients with liver cirrhosis: a multicenter retrospective study.
|
Gut Liver
|
2009
|
0.97
|
|
65
|
Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis.
|
Liver Int
|
2005
|
0.97
|
|
66
|
[Clinical features and treatment outcome of advanced hepatocellular carcinoma with inferior vena caval invasion or atrial tumor thrombus].
|
Korean J Hepatol
|
2007
|
0.97
|
|
67
|
Characterization of focal liver masses using acoustic radiation force impulse elastography.
|
World J Gastroenterol
|
2013
|
0.97
|
|
68
|
Hepatogastric fistula caused by direct invasion of hepatocellular carcinoma after transarterial chemoembolization and radiotherapy.
|
Korean J Hepatol
|
2010
|
0.97
|
|
69
|
Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma.
|
J Gastroenterol Hepatol
|
2012
|
0.96
|
|
70
|
Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis.
|
J Gastroenterol Hepatol
|
2009
|
0.95
|
|
71
|
Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-II levels.
|
Eur J Gastroenterol Hepatol
|
2012
|
0.95
|
|
72
|
A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients.
|
Liver Int
|
2010
|
0.94
|
|
73
|
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations.
|
BMC Med Genet
|
2012
|
0.94
|
|
74
|
18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.
|
Cancer
|
2011
|
0.94
|
|
75
|
Efficacy of sorafenib monotherapy versus sorafenib-based loco-regional treatments in advanced hepatocellular carcinoma.
|
PLoS One
|
2013
|
0.93
|
|
76
|
Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.
|
Hepatol Int
|
2010
|
0.93
|
|
77
|
Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement (FibroScan®).
|
Ann Surg Oncol
|
2012
|
0.93
|
|
78
|
Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis.
|
Liver Int
|
2008
|
0.93
|
|
79
|
Can preoperative diffusion-weighted MRI predict postoperative hepatic insufficiency after curative resection of HBV-related hepatocellular carcinoma? A pilot study.
|
Magn Reson Imaging
|
2010
|
0.93
|
|
80
|
Non-invasive assessment of liver fibrosis: the gap between ideal and real.
|
J Gastroenterol Hepatol
|
2011
|
0.93
|
|
81
|
Prevention of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
|
Oncology
|
2011
|
0.93
|
|
82
|
Prognostic significance of the worst grade in hepatocellular carcinoma with heterogeneous histologic grades of differentiation.
|
J Gastroenterol Hepatol
|
2013
|
0.92
|
|
83
|
Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis.
|
Cell Transplant
|
2010
|
0.92
|
|
84
|
Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma.
|
J Cancer Res Clin Oncol
|
2010
|
0.92
|
|
85
|
[Reappraisal of HBV genotypes and clinical significance in Koreans using MALDI-TOF mass spectrometry].
|
Korean J Hepatol
|
2004
|
0.90
|
|
86
|
[Association between CCR5 promoter polymorphisms and hepatitis B virus infection].
|
Korean J Hepatol
|
2005
|
0.90
|
|
87
|
Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization.
|
BMC Cancer
|
2013
|
0.90
|
|
88
|
Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.90
|
|
89
|
Transient elastography in chronic hepatitis B: an Asian perspective.
|
World J Gastroenterol
|
2010
|
0.89
|
|
90
|
How to predict HCC development in patients with chronic B viral liver disease?
|
Intervirology
|
2005
|
0.89
|
|
91
|
Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones.
|
J Gastroenterol Hepatol
|
2010
|
0.89
|
|
92
|
Rescue monotherapy in lamivudine-resistant hepatitis B e antigen-positive chronic hepatitis B: adefovir versus entecavir.
|
Antivir Ther
|
2009
|
0.89
|
|
93
|
Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection.
|
Yonsei Med J
|
2009
|
0.89
|
|
94
|
[Deficiencies in proteins C and S in a patient with idiopathic portal hypertension accompanied by portal vein thrombosis].
|
Korean J Hepatol
|
2010
|
0.88
|
|
95
|
Normal liver elasticity values using acoustic radiation force impulse imaging: a prospective study in healthy living liver and kidney donors.
|
J Gastroenterol Hepatol
|
2012
|
0.88
|
|
96
|
Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis.
|
Cancer Chemother Pharmacol
|
2012
|
0.88
|
|
97
|
Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine.
|
Vaccine
|
2012
|
0.88
|
|
98
|
Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B.
|
Clin Mol Hepatol
|
2013
|
0.88
|
|
99
|
Prevalence and genotype distribution of hepatitis C virus among apparently healthy individuals in Mongolia: a population-based nationwide study.
|
Liver Int
|
2008
|
0.88
|
|
100
|
Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.87
|
|
101
|
Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
|
Liver Int
|
2011
|
0.87
|
|
102
|
Investigation of oncogenic cooperation in simple liver-specific transgenic mouse models using noninvasive in vivo imaging.
|
PLoS One
|
2013
|
0.87
|
|
103
|
Hepatitis B e antigen-negative mutations in the precore and core promoter regions in Korean patients.
|
J Med Virol
|
2009
|
0.87
|
|
104
|
The clinical impact of early detection of the YMDD mutant on the outcomes of long-term lamivudine therapy in patients with chronic hepatitis B.
|
Antivir Ther
|
2006
|
0.87
|
|
105
|
[A case of hepaticoduodenal fistula development after transarterial chemoembolization in patient with hepatocellular carcinoma].
|
Korean J Gastroenterol
|
2011
|
0.87
|
|
106
|
Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study.
|
J Korean Med Sci
|
2010
|
0.87
|
|
107
|
Comparative study of diabetes mellitus resolution according to reconstruction type after gastrectomy in gastric cancer patients with diabetes mellitus.
|
Obes Surg
|
2012
|
0.87
|
|
108
|
Impact of spontaneous hepatocellular carcinoma rupture on recurrence pattern and long-term surgical outcomes after partial hepatectomy.
|
World J Surg
|
2014
|
0.86
|
|
109
|
Clinical features and treatment outcomes of upper gastrointestinal bleeding in patients with cirrhosis.
|
J Korean Med Sci
|
2008
|
0.86
|
|
110
|
Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study.
|
J Clin Gastroenterol
|
2013
|
0.86
|
|
111
|
Association between IL28B polymorphisms and spontaneous clearance of hepatitis B virus infection.
|
PLoS One
|
2013
|
0.86
|
|
112
|
Quantification of HBsAg: basic virology for clinical practice.
|
World J Gastroenterol
|
2011
|
0.86
|
|
113
|
Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
|
Oncology
|
2011
|
0.86
|
|
114
|
Adjuvant hepatic arterial infusional chemotherapy with 5-fluorouracil and cisplatin after curative resection of hepatocellular carcinoma.
|
Oncology
|
2011
|
0.86
|
|
115
|
Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.
|
J Gastroenterol Hepatol
|
2013
|
0.86
|
|
116
|
Inhibition of tumour angiogenesis and growth by small hairpin HIF-1α and IL-8 in hepatocellular carcinoma.
|
Liver Int
|
2013
|
0.85
|
|
117
|
A 96-week randomized trial of switching to entecavir in chronic hepatitis B patients with a partial virological response to lamivudine.
|
Antivir Ther
|
2012
|
0.85
|
|
118
|
Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.
|
J Gastroenterol Hepatol
|
2014
|
0.85
|
|
119
|
Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis.
|
Medicine (Baltimore)
|
2016
|
0.85
|
|
120
|
Role of splenectomy in patients with hepatocellular carcinoma and hypersplenism.
|
ANZ J Surg
|
2012
|
0.84
|
|
121
|
Morbidity and mortality after laparoscopic gastrectomy for advanced gastric cancer: results of a phase II clinical trial.
|
Surg Endosc
|
2013
|
0.84
|
|
122
|
Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.
|
Hepatology
|
2014
|
0.84
|
|
123
|
Surgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapy.
|
Ann Surg Oncol
|
2014
|
0.84
|
|
124
|
Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
|
Int J Cancer
|
2012
|
0.84
|
|
125
|
Optimal time for restoring the reliability of liver stiffness measurement in patients with chronic hepatitis B experiencing acute exacerbation.
|
J Clin Gastroenterol
|
2012
|
0.84
|
|
126
|
Prediction of microvascular invasion of hepatocellular carcinoma: usefulness of peritumoral hypointensity seen on gadoxetate disodium-enhanced hepatobiliary phase images.
|
J Magn Reson Imaging
|
2011
|
0.83
|
|
127
|
A case of embryonal sarcoma of the liver mimicking a hydatid cyst in an adult.
|
Gut Liver
|
2010
|
0.83
|
|
128
|
The impact of steatosis on liver stiffness measurement in patients with chronic hepatitis B.
|
Hepatogastroenterology
|
2010
|
0.83
|
|
129
|
Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma.
|
J Gastroenterol Hepatol
|
2012
|
0.83
|
|
130
|
Efficacy and safety of transarterial chemoembolization in recurrent hepatocellular carcinoma after curative surgical resection.
|
Am J Clin Oncol
|
2009
|
0.83
|
|
131
|
Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model.
|
Onco Targets Ther
|
2013
|
0.83
|
|
132
|
Factors predicting peritoneal recurrence in advanced gastric cancer: implication for adjuvant intraperitoneal chemotherapy.
|
Gastric Cancer
|
2013
|
0.83
|
|
133
|
Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first-line therapy: a Korean multicenter study.
|
J Gastroenterol Hepatol
|
2014
|
0.82
|
|
134
|
A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients.
|
J Gastrointest Surg
|
2012
|
0.82
|
|
135
|
Combination of preS deletions and A1762T/G1764A mutations in HBV subgenotype C2 increases the risk of developing HCC.
|
Intervirology
|
2011
|
0.82
|
|
136
|
External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients.
|
Dig Dis Sci
|
2009
|
0.82
|
|
137
|
Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations.
|
J Clin Gastroenterol
|
2016
|
0.82
|
|
138
|
Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.
|
Clin Mol Hepatol
|
2013
|
0.81
|
|
139
|
Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir.
|
J Clin Gastroenterol
|
2014
|
0.81
|
|
140
|
Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.
|
Medicine (Baltimore)
|
2016
|
0.81
|
|
141
|
Combination therapy of thymosin alpha-1 and lamivudine for HBeAg positive chronic hepatitis B: A prospective randomized, comparative pilot study.
|
J Gastroenterol Hepatol
|
2008
|
0.81
|
|
142
|
Lower incidence of hepatocellular carcinoma and cirrhosis in hepatitis C patients with sustained virological response by pegylated interferon and ribavirin.
|
Dig Dis Sci
|
2014
|
0.81
|
|
143
|
Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with chronic hepatitis B.
|
J Clin Gastroenterol
|
2008
|
0.81
|
|
144
|
Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.
|
Liver Int
|
2013
|
0.81
|
|
145
|
Antibody-secreting cells with a phenotype of Ki-67low, CD138high, CD31high, and CD38high secrete nonspecific IgM during primary hepatitis A virus infection.
|
J Immunol
|
2013
|
0.81
|
|
146
|
Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatment.
|
PLoS One
|
2013
|
0.81
|
|
147
|
"Normal" liver stiffness values differ between men and women: a prospective study for healthy living liver and kidney donors in a native Korean population.
|
J Gastroenterol Hepatol
|
2012
|
0.81
|
|
148
|
Long-term changes of liver stiffness values assessed using transient elastography in patients with chronic hepatitis B receiving entecavir.
|
Liver Int
|
2013
|
0.81
|
|
149
|
Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma.
|
Liver Int
|
2014
|
0.80
|
|
150
|
Correlation between quantitative serum HBsAg and HBV DNA test in Korean patients who showed high level of HBsAg.
|
J Clin Pathol
|
2010
|
0.80
|
|
151
|
Risk assessment of development of hepatic decompensation in histologically proven hepatitis B viral cirrhosis using liver stiffness measurement.
|
Digestion
|
2012
|
0.80
|
|
152
|
Sorafenib versus cytotoxic chemotherapy for patients with advanced hepatocellular carcinoma: a retrospective, single-institution study.
|
Invest New Drugs
|
2011
|
0.80
|
|
153
|
Quasispecies and pre-existing drug-resistant mutations of hepatitis B virus in patients with chronic hepatitis B.
|
Gut Liver
|
2013
|
0.80
|
|
154
|
Spontaneous bacterial peritonitis in patients with hepatitis B virus-related liver cirrhosis: community-acquired versus nosocomial.
|
Yonsei Med J
|
2012
|
0.79
|
|
155
|
Normal enhanced liver fibrosis (ELF) values in apparently healthy subjects undergoing a health check-up and in living liver donors in South Korea.
|
Liver Int
|
2013
|
0.79
|
|
156
|
A novel estimation of the relative economic value in terms of different chronic hepatitis B treatment options.
|
PLoS One
|
2013
|
0.79
|
|
157
|
Clinical features and prognosis of hepatocellular carcinoma with respect to pre-S deletion and basal core promoter mutations of hepatitis B virus Genotype C2.
|
J Med Virol
|
2011
|
0.79
|
|
158
|
Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.
|
PLoS One
|
2013
|
0.79
|
|
159
|
What is the role of diagnostic laparoscopy in a gastroenterology unit?
|
J Gastroenterol
|
2007
|
0.79
|
|
160
|
Prediction of significant fibrosis in chronic hepatitis C patients with normal ALT.
|
Hepatogastroenterology
|
2011
|
0.79
|
|
161
|
Total necrosis of hepatocellular carcinoma due to spontaneous occlusion of feeding artery.
|
Yonsei Med J
|
2002
|
0.78
|
|
162
|
Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis.
|
Liver Int
|
2014
|
0.78
|
|
163
|
Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma.
|
Onco Targets Ther
|
2013
|
0.78
|
|
164
|
Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years.
|
World J Surg Oncol
|
2014
|
0.78
|
|
165
|
Early predictor of mortality due to irreversible posthepatectomy liver failure in patients with hepatocellular carcinoma.
|
World J Surg
|
2013
|
0.78
|
|
166
|
[Concurrent chemo-radiation therapy for advanced hepatocellular carcinoma with portal vein thrombosis].
|
Taehan Kan Hakhoe Chi
|
2002
|
0.78
|
|
167
|
Transient Elastography is Superior to FIB-4 in Assessing the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
|
Medicine (Baltimore)
|
2016
|
0.78
|
|
168
|
Hepatocellular carcinoma in Budd-Chiari syndrome: a single center experience with long-term follow-up in South Korea.
|
World J Gastroenterol
|
2012
|
0.78
|
|
169
|
Reimbursement policies in the Asia-Pacific for chronic hepatitis B.
|
Hepatol Int
|
2014
|
0.78
|
|
170
|
Clinical course of virologic breakthrough after emergence of YMDD mutations in HBeAg-positive chronic hepatitis B.
|
Intervirology
|
2008
|
0.78
|
|
171
|
[The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].
|
Korean J Hepatol
|
2007
|
0.78
|
|
172
|
Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients.
|
Dig Dis Sci
|
2015
|
0.78
|
|
173
|
Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy.
|
Liver Int
|
2014
|
0.78
|
|
174
|
Community-acquired vs. nosocomial spontaneous bacterial peritonitis in patients with liver cirrhosis.
|
Hepatogastroenterology
|
2015
|
0.77
|
|
175
|
Treatment of lamivudine-resistant chronic hepatitis B infection: a multicenter retrospective study.
|
Scand J Gastroenterol
|
2012
|
0.77
|
|
176
|
"Normal" range of alanine aminotransferase levels for Asian population.
|
J Gastroenterol Hepatol
|
2011
|
0.77
|
|
177
|
[Efficacy of repeated hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma with portal vein tumor thrombosis].
|
Korean J Hepatol
|
2005
|
0.77
|
|
178
|
Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir.
|
Liver Int
|
2012
|
0.77
|
|
179
|
Partial virological response to adefovir add-on lamivudine rescue therapy in patients with lamivudine-resistant chronic hepatitis B.
|
Digestion
|
2013
|
0.77
|
|
180
|
Hepatitis B virus serology to predict antiviral response in chronic hepatitis B.
|
Digestion
|
2011
|
0.77
|
|
181
|
Predictors of refractory ascites development in patients with hepatitis B virus-related cirrhosis hospitalized to control ascitic decompensation.
|
Yonsei Med J
|
2013
|
0.77
|
|
182
|
Individual prediction model for lamivudine treatment response in hepatitis B virus e antigen-positive chronic hepatitis B patients.
|
J Gastroenterol Hepatol
|
2014
|
0.77
|
|
183
|
Pre-S mutations of hepatitis B virus affect genome replication and expression of surface antigens.
|
J Gastroenterol Hepatol
|
2014
|
0.77
|
|
184
|
Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B.
|
Liver Int
|
2014
|
0.77
|
|
185
|
Long-term clinical outcome of large volume paracentesis with intravenous albumin in patients with spontaneous bacterial peritonitis: a randomized prospective study.
|
J Gastroenterol Hepatol
|
2005
|
0.76
|
|
186
|
[Clinical outcomes of systemic chemotherapy in hepatocellular carcinoma patients with multiple lung metastases].
|
Korean J Hepatol
|
2008
|
0.76
|
|
187
|
The use of health functional foods in gastrointestinal cancer patients.
|
Clin Nutr Res
|
2013
|
0.76
|
|
188
|
Toll-like receptor polymorphisms are not associated with liver cirrhosis in hepatitis B virus infected Korean patients.
|
Hepatogastroenterology
|
2011
|
0.76
|
|
189
|
Risk Factors for Gallstone Formation in Resected Gastric Cancer Patients.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
190
|
Transient elastography in real practice: a time for action?
|
J Gastroenterol Hepatol
|
2012
|
0.75
|
|
191
|
An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES Study.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
192
|
Efficacy and long-term follow up of combination therapy with interferon alpha and ribavirin for chronic hepatitis C in Korea.
|
Yonsei Med J
|
2006
|
0.75
|
|
193
|
Acute variceal hemorrhage in patients with liver cirrhosis: weekend versus weekday admissions.
|
Yonsei Med J
|
2012
|
0.75
|
|
194
|
A case of hypervascular hyperplastic nodules in a patient with alcoholic liver cirrhosis.
|
Yonsei Med J
|
2006
|
0.75
|
|
195
|
[Predictors for virologic response in management of chronic hepatitis B].
|
Korean J Hepatol
|
2010
|
0.75
|
|
196
|
Survival of all cancer patients in Korea through 2-year follow-up.
|
J Korean Med Sci
|
2002
|
0.75
|
|
197
|
Assessment of angiogenesis of hepatocellular carcinoma using dynamic contrast enhanced MR and histopathologic correlation in an experimental rat model.
|
Hepatogastroenterology
|
2014
|
0.75
|
|
198
|
[Clinical outcome of pulmonary resections in patients with pulmonary metastasis of hepatocellular carcinoma].
|
Korean J Hepatol
|
2005
|
0.75
|
|
199
|
Clinical characteristics of acute hepatitis A complicated by acute kidney injury.
|
Scand J Infect Dis
|
2011
|
0.75
|
|
200
|
Corrigendum: Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis.
|
Am J Gastroenterol
|
2017
|
0.75
|
|
201
|
[Changes of ascites nitric oxide according to the treatment course in cirrhotic patients with spontaneous bacterial peritonitis].
|
Korean J Hepatol
|
2004
|
0.75
|
|
202
|
Prediction of esophageal variceal bleeding in B-viral liver cirrhosis using the P2/MS noninvasive index based on complete blood counts.
|
Digestion
|
2012
|
0.75
|
|
203
|
[Clinical features and prognostic factors of fulminant hepatic failure in Koreans].
|
Korean J Hepatol
|
2004
|
0.75
|
|
204
|
Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
205
|
Erratum.
|
Nephrol Dial Transplant
|
2017
|
0.75
|
|
206
|
[Natural history of HBeAg negative chronic hepatitis B virus infection: a cohort study].
|
Korean J Hepatol
|
2006
|
0.75
|
|
207
|
[A comparison of 24- vs. 48-week peginterferon plus ribavirin in patients with genotype 1 chronic hepatitis C].
|
Korean J Hepatol
|
2009
|
0.75
|
|
208
|
Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.
|
Oncology
|
2017
|
0.75
|
|
209
|
[Usefulness and safety of extracorporeal liver support therapy using MARSR for patients with liver failure: a preliminary report].
|
Korean J Gastroenterol
|
2009
|
0.75
|
|
210
|
[A case of hepatic congestion due to right heart failure mimicking liver tumor].
|
Korean J Gastroenterol
|
2010
|
0.75
|
|
211
|
Tuberculous mesenteric lymphadenitis involving the gastric wall: case report.
|
Gastrointest Endosc
|
2005
|
0.75
|
|
212
|
Relationship between severity of liver dysfunction and the relative ratio of liver to aortic enhancement (RE) on MRI using hepatocyte-specific contrast.
|
J Magn Reson Imaging
|
2013
|
0.75
|
|
213
|
Entecavir plus adefovir versus adefovir plus lamivudine in hepatitis B virus e antigen-positive, lamivudine-resistant chronic hepatitis B.
|
J Gastroenterol Hepatol
|
2014
|
0.75
|
|
214
|
Association between polymorphism of tumor necrosis factor-alpha promoter and response to lamivudine treatment in patients with chronic hepatitis B.
|
Dig Dis Sci
|
2009
|
0.75
|